The value of the deal stands at EUR15 million, with the money set to aid the company expand its product range and client base and expand internationally.
EMI founder and CEO Jerome France said the deal would allow the company to develop more rapidly in Romania and expand into the European market from here, especially to Belgium and France.
The EMI investment is the biggest for Morphosis Capital so far.
“Today’s deal marks numerous first times for us: it’s the first deal where we worked with our co-investors, and we thank them for their trust. It’s also the biggest deal so far, of a size we target for our next fund and the first investments in the field of production and services,” adds Andrei Gemeneanu, managing partner, Morphosis Capital.
EMI has a 21-year experience on the Romanian market. At its plant in Cateasca, near the town of Pitesti, EMI also develops unique technical solutions, adapted to clients’ needs.
In 2020, EMI posted a turnover above RON55 million, up 6% year-on-year. EMI-Morphosis Capital partnership aims to cement EMI’s national leading position in the field of industrial access solutions, to attract new client niches and tap new markets.
EMI is Morphosis Capital’s deal after investments carried out in DocProcess, Medima Health and Clinicile Dentare Dr. Leahu. The private equity fund expects to seal three more deals by mid-2022.
(English version by Catalina Apostoiu)